|
Wednesday 5th April 2017 |
Text too small? |
Zespri International reported strong interest in a bidding round for 400 hectares of new Gold3 or SunGold variety kiwifruit licences and said its shares will resume trading on Friday.
The kiwifruit marketer said it received 938 bids of which 235 were successful, and will reap $98 million of revenue from the allocation, excluding GST. The average size of the successful bids was 1.7 hectares. The SunGold variety has proven popular as it is more resistant to the Pseudomonas syringae pv actinadiae bacteria, better known as PSA, which decimated the industry some six years ago. By the end of June 2012, more than 35 percent of New Zealand kiwifruit orchards were infected. SunGold, first commercialised in 2010, was key to the sector's recovery.
The median price including GST was $270,250, and the minimum accepted price was $254,150. Zespri said it will update its shareholders on the impact of the licence revenue when it provides a forecast profit range for the 2017/18 year after its April board meeting.
Late last year Zespri announced it will sell licences for another 400 hectares of the SunGold variety this year, with a further 400ha to be released in 2018, 2019 and 2020 subject to the product's performance and global demand.
Earlier this month Zespri forecast it would pay $8.75-to-$9.75 per tray, or $105,000-to-$120,000 per hectare for Zespri Gold in the 2017/18 season compared to $5.15-to-$6.15 per tray or $47,500-to-$57,500 per hectare for Zespri Green.
The company will now begin notifying growers of the outcomes of their individual bids.
Zespri shares, which trade on the Unlisted share trading platform, have been in a trading halt since March 22. That halt will be lifted on Friday at 9am. The stock last traded at $4.
(BusinessDesk)
No comments yet
IKE - FY26 Financial Results
Chorus submits 2025 fibre regulatory report
SPG - FY26 Annual Results
PYS - PaySauce FY26 Full Year Result and Annual Report
IFT - Infratil Full Year Results for the year ended 31 March 2026
May 27th Morning Report
RYM - FY26 marks significant year of progress
FPH reports strong revenue and profit growth for FY26
IFT - Infratil Full Year Results for the year ended 31 March 2026
PEB - Advancing Medicare Coverage Goals; Cost Contained